D5BH:XETRA:XETRA-Xtrackers MSCI Canada ESG Screened UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 78.2

Change

-0.69 (-0.87)%

Market Cap

USD 0.36B

Volume

2.75K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.14 (-0.28%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.06 (-0.34%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.07 (-0.26%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.09 (-0.30%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.04 (-0.14%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+0.64 (+0.45%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.06 (+0.13%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.22 (-0.42%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.21 (-0.21%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.18 (-0.03%)

USD 80.38B

ETFs Containing D5BH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.54% 74% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.54% 74% C 73% C
Trailing 12 Months  
Capital Gain 28.66% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.66% 81% B- 79% B-
Trailing 5 Years  
Capital Gain 61.49% 75% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 61.49% 75% C 73% C
Average Annual (5 Year Horizon)  
Capital Gain 11.82% N/A N/A 75% C
Dividend Return 11.82% N/A N/A 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 17.21% N/A N/A 39% F
Risk Adjusted Return 68.67% N/A N/A 71% C-
Market Capitalization 0.36B 58% F 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike